Showing 2611-2620 of 2812 results for "".
- Update: Revance Starts Phase III Studies on RT002 for Frown Lineshttps://modernaesthetics.com/news/revance-starts-phase-iii-studies-on-rt002-for-frown-lines/2472297/Revance Therapeutics began two double-blind, placebo-controlled, North American Phase III trials to evaluate single injections of DaxibotulinumtoxinA (RT002) for the treatment glabellar lines in about 600 total patients. These pivotal trials
- Revealed: What A Girl Wants in a Plastic Surgeonhttps://modernaesthetics.com/news/revealed-what-a-girl-wants-in-a-plastic-surgeon/2472307/Nearly half of all female plastic surgery patients have no preference when it comes to the gender of their cosmetic surgeon, a new study show. Specifically, the report, published in Aesthetic Surgery Journal</
- Merz On The Move: Reflections On Fiscal Year 2015/16https://modernaesthetics.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2472311/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- Susan Taylorhttps://modernaesthetics.com/profiles/susan-taylor/7ZBaJv/
- Susan Taylorhttps://modernaesthetics.com/profiles/susan-taylor/7Zr0Ve/
- Mark Taylorhttps://modernaesthetics.com/profiles/mark-taylor/jJ3Nw6/
- Mark Taylorhttps://modernaesthetics.com/profiles/mark-taylor/7ZBrk1/
- Andrew Taylor, PhD, FARVOhttps://modernaesthetics.com/profiles/andrew-taylor-phd-farvo/j5ePDZ/
- Andrew Taylor, PhD, FARVOhttps://modernaesthetics.com/profiles/andrew-taylor-phd-farvo/LxAnQn/
- Andrew Taylor, PhD, FARVOhttps://modernaesthetics.com/profiles/andrew-taylor-phd-farvo/jPKkoy/